The nonavalent vaccine has been available in Italy since February 2017, and offers wider protection against the 9 most dangerous types of Papilloma viruses for men and women. The nonavalent vaccine is administered by 14 years of age in accordance with a program that calls for 2 doses. The second dose should be administered between 5 and 13 months after the first dose. After 15 years of age, those who get the vaccine can follow a 3-dose program (0, 2, and 6 months). The second dose should be administered at least one month after the first dose and the third dose at least three months after the second. All three doses should be administered within a 1 year period.
Millions of people have already been vaccinated against HPV and the safety profile of vaccines is good. Most reactions are mild and local reactions (redness, tenderness at the injection site), with muscular or joint pains, or rather, all the transient manifestations common to most vaccines. The risk/benefit ratio is greatly in favor of the benefits for future health in women that have tested positive for HPV during screening.
The theory of a possible association between vaccines and autism is entirely without foundation, so much so that the English doctor who circulated this hypothesis was removed from the Royal College (the prestigious society for British doctors) because of the documented (and admitted to by the same doctor himself) falsifying of data for the sole purpose of gaining fame! Always look for reliable sources when searching through online news, and even better, ask your gynecologist.
